Reducing breast cancer recurrence risk matters. The CATE clinical trial is investigating whether combining ctDNA monitoring with oral SERD elacestrant can help reduce future recurrence in people with early HR+/HER2- breast cancer at a higher risk of metastasis. Learn more: https://bit.ly/4aMPiWX

Join us for the 2026 Komen Health Equity Revolution Summit: a FREE virtual event bringing together leaders across public health, policy, technology & community care to discuss solutions for ensuring everyone has access to quality breast care. 📆March 5th, 10-3 pm CT Register: https://bit.ly/46UrBee

Managing treatment side effects is an important part of living with metastatic breast cancer, and you don’t have to navigate it alone. Join us for our next MBC Impact Series virtual session, “Ask a Naturopath: Side Effects Management,” on March 9 at 1 PM CT. Save your spot: https://bit.ly/4b5MwgP

"I use my voice to advocate for women, especially Black women, to trust their bodies and speak up in medical spaces. As long as I have breath, I will continue to live with purpose, faith and hope.” - Lea Read Lea's story: https://bit.ly/4s4uiCb

Steel United Soccer Club in Pennsylvania turned a simple Crossbar Challenge into a powerful youth soccer breast cancer fundraiser through our Go Pink for the Cure fundraising program. Read their story: https://bit.ly/4ksWxrq

Sending love to everyone who needs it today. Whether you're healing from treatment, grieving a loss, or years into your survivorship, we're here for you with extra love and support. Happy Valentine's Day and thank you for being a part of our community! 🩷

NEW Breast Cancer Breakthroughs today! Hear from experts and advocates as they discuss news presented at @sabcs.bsky.social and how it impacts breast cancer patients. Watch here: https://bit.ly/466uV5L

Tune in to today's Real Talk to hear how Sarah Cipolla and Tawana Davis both relied on their faith to get through breast cancer. Through it all – the ups and downs and good times and setbacks – they had hope for better days and trusted in their faith. http://bit.ly/3IderPW

If you're not already registered for the 3-Day, now's the time! Today is the last day for 50% off registration with code EARLYBIRD at www.the3day.org/register

Live Q&A with Dr. Adam Brufsky of the University of Pittsburgh to talk about treating & coping w/ bone metastases. 🗓️ Feb. 20th; 1 PM CT This free virtual session is a chance to get reliable info and ask the questions that matter most to you. Register: https://bit.ly/3ZhwkCE

This World Cancer Day, we're highlighting advancements made in breast cancer care thanks to your support. We're grateful for this community, we remember those we've lost, and send love to those living with breast cancer and their loved ones and caregivers. #WorldCancerDay

Congress has passed the FY26 budget, incl. funding increase wins for breast cancer research and safety net programs. We have been unified in defending these lifesaving programs from proposed cuts. Advocates, this victory belongs to YOU. Thank you! https://bit.ly/4qfxLwk

Tune into today's episode of Real Pink to hear how after having to fight for an initial screening and not experiencing transparency from her doctor, Lea Leach kept advocating for herself and is now living a life filled with purpose, courage and faith. http://bit.ly/3IderPW

Breaking news! We are thrilled to announce the artist line-up for our Band As One Concert for the Cure in Nashville on March 22! This incredible night of music will fuel our fight to end breast cancer forever! Get your tickets today at https://bit.ly/4owKjPA

🧬 Have you heard of “ctDNA” or “MRD” as they relate to breast cancer care but aren’t sure what they mean? Learn about ctDNA (circulating tumor DNA) and how it's being used now vs. what’s still being studied. Read the Know More blog: https://bit.ly/4k4aYSQ

On today's episode of Real Pink, Joi White shares how she navigated breast cancer as a Black woman facing cultural expectations and discovered that softening and advocating for herself was the real pathway to healing. Listen http://bit.ly/3IderPW

Don’t miss your chance to win 2 tickets to Super Bowl LX on Feb 8, 2026 at Levi’s Stadium in Santa Clara, California! Every entry is way to give help and hope to those whose lives have been turned upside down by breast cancer. For details & more info about how to enter visit: Komen.org/BigGame2026

Don't forget to sprinkle a few moments of self-love throughout the day!⁠ What would you add to this list?

Want to learn more about the latest advancements for those living with MBC? Join us on Jan. 27 at 12pm CT to learn the newest and most exciting findings from the recent @SABCSSanAntonio. Register for this free virtual event: https://bit.ly/3LMpJgb

Join us and urge Congress: it’s time to say YES to lifesaving funding! Federal lawmakers are close to an agreement on a health care funding plan. Tell Congress to protect and grow lifesaving breast cancer research and care programs. ACT NOW to join us! https://bit.ly/YESfy26

The color of your skin shouldn’t make it harder to get the equitable, high-quality care you deserve when diagnosed with breast cancer. Together we can make health equity a priority for all people. Learn more about our commitment to Stand for H.E.R here: https://bit.ly/3KR4C7c

Through ShareForCures, we’ll connect different types of health data from thousands of people over time to create one of the most valuable tools available for breast cancer research. You can help discover cures for breast cancer, faster. Learn more: https://www.komen.org/shareforcures/

Komen’s Center for Public Policy announced its 2026 federal and state advocacy priorities, underscoring the need to protect affordability of and access to high-quality health care for the breast cancer community. Learn more: https://bit.ly/45HZmyN

It’s important to remember that just because you have a risk factor doesn’t mean that you will get breast cancer. Talk with your doctor about your risk of breast cancer and together develop a breast cancer screening plan that’s right for you. Learn more at komen.org

“Am I eligible for a clinical trial?” Clinical trials aren’t a last resort. They help create better options & exist at every stage. 📖 Read more from our latest Know More blog: https://bit.ly/3LDaXZd

Join us in the fight against breast cancer and you could score big! Like Super Bowl BIG. Enter now for your chance to win 2 tickets to Super Bowl LX on Feb. 8, 2026 at Levi’s Stadium in Santa Clara, CA! For details & more info about how to enter visit: Komen.org/BigGame2026

There is no way around it, breast cancer is hard. But as today's guest on Real Pink will tell you, trying to remain upbeat throughout treatment can have a positive impact on your life. Listen today: http://bit.ly/3IderPW

Yes, it's true! Breast cancer can also affect men. Head to our website to learn everything you need to know about male breast cancer, from warning signs to support resources: https://bit.ly/43p0HJA

The early bird catches the discount! Register today for 50% off your 2026 registration with code EARLYBIRD at www.the3day.org/register. Hurry before this promotion flies away!

Let's make 2026 the year of healthy living! Taking care of yourself and having a sense of happiness and well-being is an important part of your health. What new things do you want to try this year?

Our “EmpowerED: Education After Diagnosis” event took place on Dec. 8, bringing together attendees for an evening of education, support and meaningful conversations, including a discussion about the power of asking for help and supporting one another. https://bit.ly/48KDOUk

Update! FDA approves T-DXd (trastuzumab deruxtecan) combined with petuzumab for HER2+ metastatic breast cancer as 1st line treatment - backed by DESTINY-Breast09 clinical trial results. Learn more here: https://bit.ly/4pIyc2V

"It's so important to always have advocates involved because it allows us to ask those questions to researchers like 'how will this help?'" - Komen patient advocate Bob Ritter shares his thoughts on all the research updates coming from @sabcs.bsky.social #SABCS

This week at #SABCS25, we presented pivotal work aimed at addressing needs within the #breastcancer community. Read more about the Komen-led research projects: https://bit.ly/4pyiJCe @sabcs.bsky.social#SABCS25

🔬 We’re watching the science at #SABCS25. Komen Scholar Susan Domchek, M.D., is excited about the WISDOM trial using genetics & polygenic risk scores to personalize screening. @sabcs.bsky.social#SABCS25 📖 Read more: https://www.komen.org/blog/sabcs-watch-2025/

🚀 At #SABCS25, Ben Park, MD, PhD showed how cell signals go "off the rails" in breast cancer and how his groundbreaking work with cfDNA is changing care by helping earlier detection, better treatment tracking, and spotting metastasis sooner. @sabcs.bsky.social

🎉 Congrats to Komen grantees Armando Giuliano MD and Nolan Priedigkeit MD for receiving awards at this year’s @sabcs.bsky.social! #SABCS25 👏👏

📢 We’re at #SABCS25! Stop by our booth in the Patient Advocacy Pavilion in the @sabcs.bsky.social#SABCS25Exhibition Hall! We’d love to talk to you about Komen’s mission including patient navigation, policy, research-support, education, and more!

Komen Scholar and Advocates in Science Steering Committee member Barbara Segarra-Vazquez highlights how advocates can drive meaningful change across research in the Partnership for Change session at #SABCS25. @sabcs.bsky.social

Komen grantee David Cescon discusses exciting advances in liquid biopsy tests for early breast cancer presented at #SABCS25. @sabcs.bsky.social

Komen Scholar Reshma Jagsi M.D., D. Phil. highlighted research at #SABCS25 that could reduce the burden of treatment, like fewer lymph node surgeries & radiation that boosts the immune system. 📖 See what’s ahead and what we’re excited to learn about @sabcs.bsky.social#SABCS25here: https://bit.ly/4pWBEqa

👏Komen honored our new early-career grantees during a celebration at #SABCS25. We are so proud to support the next generation of breast cancer leaders, investing in a talented workforce for years to come! 🎉 Learn more: https://bit.ly/49prhq1 @sabcs.bsky.social#SABCS25

Komen Scholar, Dr. Sunil Badve, presented how immune cells in residual tumors vary by breast cancer subtype in the ECOG-ACRIN EA1131 trial at #SABCS25. @sabcs.bsky.social

Another DESTINY-Breast09 update from Mothaffar Rimawi MD at #SABCS25: in HER2+ advanced breast cancer, first-line T-DXd + pertuzumab kept pain and daily functioning similar to standard THP, with more stomach issues but fewer skin and swelling symptoms 🩺📈 @sabcs.bsky.social

🩺🧬 Shanu Modi, MD shared DESTINY-Breast11 patient-reported outcomes: In high-risk HER2+ early breast cancer, T-DXd–based pre-surgery therapy helped more patients keep up physical functioning & daily activities vs ddAC-THP, with overall manageable side effects #SABCS25

At #SABCS25, Kevin Punie MD presented on ASCENT-03 patient-reported outcomes: In untreated advanced TNBC not eligible for immunotherapy, sacituzumab govitecan helped patients maintain physical activity and overall well-being better than chemo @sabcs.bsky.social

At #SABCS25, Jean Wright MD presented results from RadComp: In locally advanced breast cancer, proton radiation therapy gave lower average doses to the heart than photon RT. 💓 At 6 months, heart-related quality of life looked similar overall, with fatigue back to baseline @sabcs.bsky.social

At #SABCS25, Dr. Curigliano shared DESTINY-Breast11 data in high-risk HER2+ early breast cancer: T-DXd–based neoadjuvant regimens showed a more favorable safety profile, with fewer serious toxicities compared with ddAC-THP, while keeping side effects manageable 🩺🧬 @sabcs.bsky.social

💡 Komen Scholar Ben Park MD shares some hot topics at #SABCS25, including blood tests (liquid biopsies) that could transform how we detect and track #breastcancer. 📖 Read more about what we're watching @sabcs.bsky.social#SABCS25#breastcancerere: https://www.komen.org/blog/sabcs-watch-2025/

We’re tracking the biggest updates from #SABCS25, from liquid biopsies to genetics-guided screening🧬 #Breastcancer experts & MD’s: Ben Park, Reshma Jagsi & Susan Domchek shared what they’re watching & why it matters for patients in our blog: https://www.komen.org/blog/sabcs-watch-2025/ 💬